Harrison D E
Mech Ageing Dev. 1979 Mar;9(5-6):427-33. doi: 10.1016/0047-6374(79)90083-6.
Marrow stem cell lines from old and young donors in parallel experiments were transplanted into genetically anemic W/WV recipients. These recipients were populated and their anemias were cured by stem cell lines from WCB6F1 or C57BL/6 dorons that had been repeatedly transplanted up to five times at annual intervals into successive W/WV recipients. Old marrow cell lines produced erythrocytes normally for as long as 2600 to 3000 days. However, after three to four serial transplantations many stem cell lines failed to cure at least two-thirds of the recipients, and all failed by transplantation six. This decline occurred in a similar pattern whether the original stem line donor was old or young. Two experiments suggested that the decline was caused by the transplantation procedure: (1) chromosomally marked donor cells from old and young donors permanently populated lymph nodes in lethally irradiated recipients after the first transplantation, but under the same conditions cell lines from the same donors transplanted a second time were substantially infiltrated by regenerating recipient cells; (2) the ability to compete with the same chromosomally marked cell line in populating irradiated recipients declined markedly in both old and young marrow stem cell lines that had been previoulsy transplanted.
在平行实验中,将来自老年和年轻供体的骨髓干细胞系移植到遗传性贫血的W/WV受体中。这些受体由来自WCB6F1或C57BL/6供体的干细胞系进行植入,这些供体的干细胞系已按年度间隔重复移植多达五次至连续的W/WV受体中,从而治愈了它们的贫血。老年骨髓细胞系能够正常产生红细胞长达2600至3000天。然而,经过三到四次连续移植后,许多干细胞系无法治愈至少三分之二的受体,并且在第六次移植时全部失败。无论原始干细胞系供体是老年还是年轻,这种衰退都以类似的模式发生。两项实验表明,这种衰退是由移植过程引起的:(1)来自老年和年轻供体的经染色体标记的供体细胞在首次移植后永久性地植入了接受致死性照射的受体的淋巴结中,但在相同条件下,来自相同供体的细胞系第二次移植时被再生的受体细胞大量浸润;(2)在植入受照射受体方面,与相同经染色体标记的细胞系竞争的能力在先前已移植的老年和年轻骨髓干细胞系中均明显下降。